Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-11 02:37:10 EDT

Explore

PostsPeople
LatestRanked
@onc-rg.bsky.socialOct 2, 2026, 12:07 AM

๐™๐™๐™š 2026 ๐™€๐™Ž๐™ˆ๐™Š ๐™‡๐˜ฝ๐˜ผ ๐™‡๐™–๐™ฃ๐™™๐™จ๐™˜๐™–๐™ฅ๐™š: ๐™‘๐™ž๐™จ๐™ช๐™–๐™ก๐™ž๐™ฏ๐™š๐™™.
Which mechanisms are commanding the late-breaker spotlight this year?

#ESMO2026 #ESMO26 #Oncology #NSCLC #SCLC #ADCs #vaccines #ClinicalData #DrugTrials #CompetitiveStrategy

Our analysts crunched the numbers across all LBAs: โœ”๏ธADCs lead the field โ€” nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond โœ”๏ธCheckpoint inhibition isn't just a category โ€” it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more โœ”๏ธBeyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO Stay ahead of the competitive curve with verified insights. Our analysts crunched the numbers across all LBAs: โœ”๏ธADCs lead the field โ€” nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond โœ”๏ธCheckpoint inhibition isn't just a category โ€” it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more โœ”๏ธBeyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO Stay ahead of the competitive curve with verified insights.
@passback.bsky.socialSep 14, 2026, 10:08 PM

at $8โ€“12 CPM, while a premium spot runs many times that.
Start around $50.
Clear viewability reporting.

PassBack: start around $50. $8โ€“12 CPM. No contracts. We nail competitive TV strategy. passback.tv

#PassbackCTV #TVAds #StreamingAds #MarketingStrategy #CompetitiveStrategy #MediaBuying